BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2249071)

  • 1. Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.
    Devereux S; Selassie TG; Vaughan Hudson G; Vaughan Hudson B; Linch DC
    BMJ; 1990 Nov; 301(6760):1077-80. PubMed ID: 2249071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
    BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
    Tester WJ; Kinsella TJ; Waller B; Makuch RW; Kelley PA; Glatstein E; DeVita VT
    J Clin Oncol; 1984 Jul; 2(7):762-9. PubMed ID: 6547479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia following Hodgkin's disease.
    Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
    N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease.
    Mendenhall NP; Shuster JJ; Million RR
    Radiother Oncol; 1989 Mar; 14(3):219-29. PubMed ID: 2710953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary leukemia following treatment for Hodgkin's disease.
    Salvagno L; Simonato L; SorarĂ¹ M; Bianco A; Chiarion-Sileni V; Aversa SM; Camporese R; Garofolin P; Fiorentino M
    Tumori; 1993 Apr; 79(2):103-7. PubMed ID: 8346559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease terminating in acute leukaemia: report of seven cases.
    Wolf MM; Cooper IA; Ding JC
    Aust N Z J Med; 1979 Aug; 9(4):398-402. PubMed ID: 292379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute leukaemia in patients treated for Hodgkin's disease.
    Papa G; Mauro FR; Anselmo AP; Cimino G; Alimena G; Amadori S; D'Arcangelo E; Giannarelli D; Bosi A; Bellesi G
    Br J Haematol; 1984 Sep; 58(1):43-52. PubMed ID: 6466571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
    van Leeuwen FE; Chorus AM; van den Belt-Dusebout AW; Hagenbeek A; Noyon R; van Kerkhoff EH; Pinedo HM; Somers R
    J Clin Oncol; 1994 May; 12(5):1063-73. PubMed ID: 8164031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria.
    Gardner MJ; Snee MP; Hall AJ; Powell CA; Downes S; Terrell JD
    BMJ; 1990 Feb; 300(6722):423-9. PubMed ID: 2107892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
    J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    Blayney DW; Longo DL; Young RC; Greene MH; Hubbard SM; Postal MG; Duffey PL; DeVita VT
    N Engl J Med; 1987 Mar; 316(12):710-4. PubMed ID: 3821809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkitt leukaemia following chemoradiotherapy in a patient with Hodgkin's disease.
    Brenner B; Nagler A; Ben-Arieh Y; Steiner M
    Clin Lab Haematol; 1986; 8(2):163-4. PubMed ID: 3731730
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy.
    Swerdlow AJ; Douglas AJ; Vaughan Hudson G; Vaughan Hudson B; MacLennan KA
    Br J Cancer; 1993 Nov; 68(5):1006-11. PubMed ID: 8217588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.